Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$140.68 - $188.02 $92,848 - $124,093
-660 Reduced 31.49%
1,436 $233,000
Q1 2022

May 13, 2022

SELL
$161.19 - $257.96 $65,443 - $104,731
-406 Reduced 16.23%
2,096 $394,000
Q4 2021

Feb 14, 2022

SELL
$247.59 - $304.47 $1.21 Million - $1.49 Million
-4,881 Reduced 66.11%
2,502 $663,000
Q3 2021

Nov 09, 2021

BUY
$194.77 - $324.21 $1.44 Million - $2.39 Million
7,383 New
7,383 $2.13 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.94B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Marietta Investment Partners LLC Portfolio

Follow Marietta Investment Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marietta Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marietta Investment Partners LLC with notifications on news.